Eléments de l'association

	Sophia Zoungas	7
	Perindopril (therapeutic use)	2
	Sophia Zoungas *Sauf* Perindopril (therapeutic use)"	6
	Perindopril (therapeutic use) *Sauf* Sophia Zoungas"	1
	Sophia Zoungas Et Perindopril (therapeutic use)	1
	Sophia Zoungas Ou Perindopril (therapeutic use)	8
	*Corpus*	3114

List of bibliographic references

Number of relevant bibliographic references: 1.

Ident.	Authors (with country if any)	Title
000605	Muh Geot Wong [Australie] ; Vlado Perkovic [Australie] ; John Chalmers [Australie] ; Mark Woodward [États-Unis] ; Qiang Li [Australie] ; Mark E. Cooper [Australie] ; Pavel Hamet [Canada] ; Stephen Harrap [Australie] ; Simon Heller [Royaume-Uni] ; Stephen Macmahon [Royaume-Uni] ; Giuseppe Mancia [Italie] ; Michel Marre [France] ; David Matthews [Royaume-Uni] ; Bruce Neal [Royaume-Uni] ; Neil Poulter [Royaume-Uni] ; Anthony Rodgers [Australie] ; Bryan Williams [Royaume-Uni] ; Sophia Zoungas [Australie]	Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON.

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024